About Us


 

Source Code Capital is a most entrepreneurial investment company.

Since its founding in the spring of 2014, Source Code Capital has been committed to create real and enduring value through investment. With a total asset under management of over USD 6 billion and investments in over 300 startup companies, including ByteDance, Meituan (3690.HK), KE Holdings (NYSE:BEKE), Li Auto (NASDAQ: LI, 2015.HK), Unitree Robotics, ESWIN Material, Blokees (00325.HK), RELX (NYSE:RLX), Yuanbao (NASDAQ:YB), Tastien, and Sibionics – and many others. Our portfolio companies cover seed, early, and growth stages, across industries such as Artificial Intelligence and Robotics, Intelligent Manufacturing, Internet & Consumption, Healthcare and Biotech+.

Source Code Capital embraces value investing. We believe in the enduring power of fundamental principles, and we focus on generational innovation, top-tier business models, and exceptional corporate cultures. Through our investments, we aim to help more companies become global leaders with sustainable growth.

Source Code Capital values outstanding entrepreneurs. We are dedicated to partnershing with resilient and visionary founders, leveraging the power of technology and management to drive business transformation. We strive to provide a comprehensive support system that connects entrepreneurs via the Code Class ecosystem, enhances entrepreneurial insights via Code Brain courses, and drives entrepreneurial success via Code Power Professional Service.

Source Code Capital maintains an entrepreneurial mindset. We continuously pursue the core principles that shapes business and society, embracing the joy of discovery and growth. We turn insight into action—doing what’s right for the times and delivering lasting value. Our hearts reach wide, our exploration never ends.

Industry Recognition


2021 Midas List by Forbes
2021 China’s Most Influencial Investors TOP30 by Fortune China
2021 China’s Most Popular Venture Capital Institution for Entrepreneurs TOP100 by 36Kr
2021 China’s Most Popular Venture Capital Institution for LP TOP50 by 36Kr
2021 Best Investor in Healthcare and Biotech by Huxiu
2021 China’s Best Post-Investment Services Venture Capital Institution TOP10 by Securities Times
2020 Midas List by Forbes
2020 Midas Brink List by Forbes
2020 China Venture Capital Institution TOP100 by Zero2IPO Group
2020 China’s Most Popular Venture Capital Institution for Entrepreneurs TOP100 by 36Kr
China Venture 2020 China’s Best Venture Investors Top100
TOP30 Venture Capital Institution of the Year 2020 by Jiemian
2019 Midas List by Forbes
2018 Midas List by Forbes
2018 China’s 30 Most Influential Investors by Fortune China
2018 China Venture Capital Institution TOP50(TOP20)by Zero2IPO Group
2018 TOP20 China’s Investment Firms in Consumer/Life by Zero2IPO Group
2018 China’s Most Influencial Venture Capital Institution TOP10 by 36Kr
2018 China’s Most Popular Venture Capital Institution for Entrepreneurs TOP100 by 36Kr
2018 China’s Most Popular Investor for Entrepreneurs TOP100 by 36Kr
2018 TOP1000 Global Top Scientists in Computer Science and Electronics
China Venture 2017 China’s Best Return Venture Capital Institution TOP10
China Venture 2017 China’s Best Venture Investors Top100
Sina 2017 China’s Best Investor Ranking List TOP25
2017 China’s Most Popular Investor for Entrepreneurs TOP100 by 36Kr
40 Business Elites Under 40 in 2016 by Fortune China
Angel Investor of the Year 2016 by Chuangyebang
Investor of the Year 2016 by iHeima
40 Under 40 in 2016 by Chuangyebang
Best Chinese Venture Capital Investors in 2016 by China Venture – FT Chinese
China Leading Investors Top100 by Zero2IPO Group